Abbott India Limited
ABBOTINDIA
Pozycja w akcjach
#3029
Abbott India Limited is a pharmaceutical enterprise that conducts its... Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.
Cena akcji
$284.73
Kapitalizacja rynkowa
$6.05B
Zmiana (1 dzień)
-0.41%
Zmiana (1 rok)
-17.16%
Kraj
IN
Handel Abbott India Limited (ABBOTINDIA)
Kategoria
Healthcare
Zyski dla Abbott India Limited (ABBOTINDIA)
Zyski w Jun 2026 TTM: $238.19M
Według najnowszych raportów finansowych Abbott India Limited, obecny zysk firmy wynosi $238.19M. W roku 2024 firma osiągnęła zysk w wysokości $194.01M, wzrost w porównaniu do zysku z roku 2023, który wynosił $155.00M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Abbott India Limited od 2004 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $238.19M | 7.96% |
| 2025 | $220.63M | 13.72% |
| 2024 | $194.01M | 25.17% |
| 2023 | $155.00M | 8.97% |
| 2022 | $142.24M | 12.45% |
| 2021 | $126.49M | 18.71% |
| 2020 | $106.55M | 5.87% |
| 2019 | $100.64M | 5.44% |
| 2018 | $95.45M | 41.81% |
| 2017 | $67.31M | 12.04% |
| 2016 | $60.08M | 8.86% |
| 2015 | $55.19M | 39.00% |
| 2014 | $39.70M | 1.44% |
| 2012 | $39.14M | 15.33% |
| 2011 | $33.94M | 61.11% |
| 2010 | $21.06M | -16.67% |
| 2009 | $25.28M | 33.27% |
| 2008 | $18.97M | -26.36% |
| 2007 | $25.76M | 31.50% |
| 2006 | $19.59M | 3.19% |
| 2005 | $18.98M | -38.51% |
| 2004 | $30.87M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $33.60B | 14,004.37% |
US
|
|
| $17.74B | 7,346.49% |
US
|
|
| $8.70B | 3,552.08% |
US
|
|
| $5.95B | 2,397.14% |
US
|
|
| $21.39B | 8,879.40% |
CH
|
